Biotech News

NOMAD POWER SOLUTIONS ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS

Lixte Biotechnology Holdings (LIXT)Lixte Biotechnology HoldingsCommercial

BOCA RATON, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. ("NOMAD" or the "Company") (Nasdaq: NMAD) (formerly LIXTE Biotechnology Holdings), a provider of transportable, utility-grade battery energy storage systems through its wholly owned subsidiary NOMAD Transportable Power Systems, today announced that the Company’s Special Meeting of Stockholders (the “Special Meeting”), originally convened at 1:00 PM Eastern Time on September 4, 2026, was adjourned without conducting any business and will reconvene on October 2, 2026 at 1:00 PM Eastern Time, in order to provide the Company additional time to complete and finalize its Nasdaq listing application.

No changes have been made to the proposals to be voted on at the Special Meeting. The Board of Directors continues to recommend that stockholders vote “FOR” the proposals. Stockholders who have already submitted their proxies and do not wish to change their votes need not take any further action. The reconvened Special Meeting will be held virtually at www.virtualshareholdermeeting.com/NMAD2026SM .

The Company's proxy statement and any other materials filed by the Company with the SEC can be obtained free of charge at the SEC's website at www.sec.gov .

About NOMAD Power Solutions, Inc.

NOMAD Power Solutions, Inc., through its wholly owned subsidiary NOMAD Transportable Power Systems, provides transportable, utility-grade battery energy storage systems. The company's mobile battery energy storage system (BESS) platforms deliver rapidly deployable, scalable energy solutions for electric utilities, data centers, commercial and industrial customers, emergency response, renewable energy integration, and grid modernization. By mobilizing energy storage, NOMAD enables customers to deploy power where and when it is needed without waiting for permanent infrastructure.

For more information, please visit https://ir.nomadpower.com/ .

# # #

Investor and Media Contact:

PondelWilkinson [email protected]

Todd Kehrli: (310) 279-5961; [email protected] Michael Wichman: (917) 526-0855; [email protected]

Source: NOMAD Power Solutions, Inc. Released September 4, 2026

Related news

Lixte Biotechnology Holdings

PP2A Inhibition in Cancer LIXTE Biotechnology develops cancer therapies based on inhibition of protein phosphatase 2A. Its lead molecule is intended to sensitize tumors to chemotherapy and immunotherapy rather than function solely as a stand-alone cytotoxic drug. LB-100 LB-100 is a first-in-class clinical PP2A inhibitor that has shown...

Recent company news

Stock data

Close
7.21 USD
Market cap
87.18M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States